Your browser doesn't support javascript.
loading
Association of body shape phenotypes and body fat distribution indexes with inflammatory biomarkers in the European Prospective Investigation into Cancer and Nutrition (EPIC) and UK Biobank.
González-Gil, Esther M; Peruchet-Noray, Laia; Sedlmeier, Anja M; Christakoudi, Sofia; Biessy, Carine; Navionis, Anne-Sophie; Mahamat-Saleh, Yahya; Jaafar, Rola F; Baurecht, Hansjörg; Guevara, Marcela; Etxezarreta, Pilar Amiano; Verschuren, W M Monique; Boer, Jolanda M A; Olsen, Anja; Tjønneland, Anne; Simeon, Vittorio; Castro-Espin, Carlota; Aune, Dagfinn; Heath, Alicia K; Gunter, Marc; Colorado-Yohar, Sandra M; Zilhão, Nuno R; Dahm, Christina C; Llanaj, Erand; Schulze, Matthias B; Petrova, Dafina; Sieri, Sabina; Ricceri, Fulvio; Masala, Giovanna; Key, Tim; Viallon, Vivian; Rinaldi, Sabina; Freisling, Heinz; Dossus, Laure.
Afiliação
  • González-Gil EM; Nutrition and Metabolism Branch, International Agency for Research On Cancer, World Health Organization, 69372, Lyon, CEDEX 08, France.
  • Peruchet-Noray L; Nutrition and Metabolism Branch, International Agency for Research On Cancer, World Health Organization, 69372, Lyon, CEDEX 08, France.
  • Sedlmeier AM; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
  • Christakoudi S; Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
  • Biessy C; Center for Translational Oncology, University Hospital Regensburg, Regensburg, Germany.
  • Navionis AS; Bavarian Cancer Research Center (BZKF), Regensburg, Germany.
  • Mahamat-Saleh Y; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Jaafar RF; Nutrition and Metabolism Branch, International Agency for Research On Cancer, World Health Organization, 69372, Lyon, CEDEX 08, France.
  • Baurecht H; Nutrition and Metabolism Branch, International Agency for Research On Cancer, World Health Organization, 69372, Lyon, CEDEX 08, France.
  • Guevara M; Nutrition and Metabolism Branch, International Agency for Research On Cancer, World Health Organization, 69372, Lyon, CEDEX 08, France.
  • Etxezarreta PA; Nutrition and Metabolism Branch, International Agency for Research On Cancer, World Health Organization, 69372, Lyon, CEDEX 08, France.
  • Verschuren WMM; Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
  • Boer JMA; Instituto de Salud Pública y Laboral de Navarra, 31003, Pamplona, Spain.
  • Olsen A; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain.
  • Tjønneland A; Navarra Institute for Health Research (IdiSNA), 31008, Pamplona, Spain.
  • Simeon V; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain.
  • Castro-Espin C; Sub Directorate for Public Health and Addictions of Gipuzkoa, Ministry of Health of the Basque Government, San Sebastian, Spain.
  • Aune D; Epidemiology of Chronic and Communicable Diseases Group, BioGipuzkoa (BioDonostia) Health Research Institute, San Sebastián, Spain.
  • Heath AK; Centre forPrevention, Lifestyle and Health, National Institute for Public Health and the Environment, PO Box 1, 3720 BA, Bilthoven, the Netherlands.
  • Gunter M; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Colorado-Yohar SM; Centre forPrevention, Lifestyle and Health, National Institute for Public Health and the Environment, PO Box 1, 3720 BA, Bilthoven, the Netherlands.
  • Zilhão NR; Danish Cancer Institute, Danish Cancer Society, Diet, Cancer and Health Strandboulevarden 49 2100, Copenhagen, Denmark.
  • Dahm CC; Department of Public Health, University of Aarhus, Copenhagen, Denmark.
  • Llanaj E; Danish Cancer Institute, Danish Cancer Society, Diet, Cancer and Health Strandboulevarden 49 2100, Copenhagen, Denmark.
  • Schulze MB; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Petrova D; Dipartimento Di Salute Mentale E Fisica E Medicina Preventiva, Università Degli Studi Della Campania 'Luigi Vanvitelli', Napoli, Italy.
  • Sieri S; Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Ricceri F; Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Masala G; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Key T; Department of Research, The Cancer Registry of Norway, Oslo, Norway.
  • Viallon V; Department of Nutrition, Oslo New University College, Oslo, Norway.
  • Rinaldi S; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Freisling H; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Dossus L; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain.
BMC Med ; 22(1): 334, 2024 Aug 15.
Article em En | MEDLINE | ID: mdl-39148045
ABSTRACT

BACKGROUND:

The allometric body shape index (ABSI) and hip index (HI), as well as multi-trait body shape phenotypes, have not yet been compared in their associations with inflammatory markers. The aim of this study was to examine the relationship between novel and traditional anthropometric indexes with inflammation using data from the European Prospective Investigation into Cancer and Nutrition (EPIC) and UK Biobank cohorts.

METHODS:

Participants from EPIC (n = 17,943, 69.1% women) and UK Biobank (n = 426,223, 53.2% women) with data on anthropometric indexes and C-reactive protein (CRP) were included in this cross-sectional analysis. A subset of women in EPIC also had at least one measurement for interleukins, tumour necrosis factor alpha, interferon gamma, leptin, and adiponectin. Four distinct body shape phenotypes were derived by a principal component (PC) analysis on height, weight, body mass index (BMI), waist (WC) and hip circumferences (HC), and waist-to-hip ratio (WHR). PC1 described overall adiposity, PC2 tall with low WHR, PC3 tall and centrally obese, and PC4 high BMI and weight with low WC and HC, suggesting an athletic phenotype. ABSI, HI, waist-to-height ratio and waist-to-hip index (WHI) were also calculated. Linear regression models were carried out separately in EPIC and UK Biobank stratified by sex and adjusted for age, smoking status, education, and physical activity. Results were additionally combined in a random-effects meta-analysis.

RESULTS:

Traditional anthropometric indexes, particularly BMI, WC, and weight were positively associated with CRP levels, in men and women. Body shape phenotypes also showed distinct associations with CRP. Specifically, PC2 showed inverse associations with CRP in EPIC and UK Biobank in both sexes, similarly to height. PC3 was inversely associated with CRP among women, whereas positive associations were observed among men.

CONCLUSIONS:

Specific indexes of body size and body fat distribution showed differential associations with inflammation in adults. Notably, our results suggest that in women, height may mitigate the impact of a higher WC and HC on inflammation. This suggests that subtypes of adiposity exhibit substantial variation in their inflammatory potential, which may have implications for inflammation-related chronic diseases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Distribuição da Gordura Corporal Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Distribuição da Gordura Corporal Idioma: En Ano de publicação: 2024 Tipo de documento: Article